Regulation of TOR by small GTPases

被引：82
作者：
Duran, Raul V. [1 ]
Hall, Michael N. [1 ]
机构：
[1] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland
来源：
EMBO REPORTS | 2012年 / 13卷 / 02期
基金：
瑞士国家科学基金会;
关键词：
TOR; Rheb; Rag; RalA; Rac1; Ryh1; COMPLEX; 1; MTORC1; MAMMALIAN TARGET; PHOSPHOLIPASE-D; SACCHAROMYCES-CEREVISIAE; AMINO-ACIDS; FISSION YEAST; CELL-GROWTH; MEDIATED PHOSPHORYLATION; RAPAMYCIN-RESISTANCE; ACTIN CYTOSKELETON;
D O I：
10.1038/embor.2011.257
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TOR is a conserved serine/threonine kinase that responds to nutrients, growth factors, the bioenergetic status of the cell and cellular stress to control growth, metabolism and ageing. A diverse group of small GTPases including Rheb, Rag, Rac1, RalA and Ryh1 play a variety of roles in the regulation of TOR. For example, while Rheb binds to and activates TOR directly, Rag and Rac1 regulate its localization and RalA activates it indirectly through the production of phosphatidic acid. Here, we review recent findings on the regulation of TOR by small GTPases.
引用
收藏
页码：121 / 128
页数：8
相关论文
共 90 条
  • [1] Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities
    Agola, J. O.
    Jim, P. A.
    Ward, H. H.
    BasuRay, S.
    Wandinger-Ness, A.
    [J]. CLINICAL GENETICS, 2011, 80 (04) : 305 - 318
  • [2] Amino acid regulation of TOR complex 1
    Avruch, Joseph
    Long, Xiaomeng
    Ortiz-Vega, Sara
    Rapley, Joseph
    Papageorgiou, Angela
    Dai, Ning
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (04): : E592 - E602
  • [3] Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation
    Barquilla, Antonio
    Crespo, Jose L.
    Navarro, Miguel
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (38) : 14579 - 14584
  • [4] Targeting protein prenylation for cancer therapy
    Berndt, Norbert
    Hamilton, Andrew D.
    Sebti, Said M.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (11) : 775 - 791
  • [5] The Vam6 GEF Controls TORC1 by Activating the EGO Complex
    Binda, Matteo
    Peli-Gulli, Marie-Pierre
    Bonfils, Gregory
    Panchaud, Nicolas
    Urban, Joerg
    Sturgill, Thomas W.
    Loewith, Robbie
    De Virgilio, Claudio
    [J]. MOLECULAR CELL, 2009, 35 (05) : 563 - 573
  • [6] GEFs and GAPs: Critical elements in the control of small G proteins
    Bos, Johannes L.
    Rehmann, Holger
    Wittinghofer, Alfred
    [J]. CELL, 2007, 129 (05) : 865 - 877
  • [7] Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning
    Cai, SL
    Tee, AR
    Short, JD
    Bergeron, JM
    Kim, J
    Shen, JJ
    Guo, RF
    Johnson, CL
    Kiguchi, K
    Walker, CL
    [J]. JOURNAL OF CELL BIOLOGY, 2006, 173 (02) : 279 - 289
  • [8] Phospholipase D confers rapamycin resistance in human breast cancer cells
    Chen, YH
    Zheng, Y
    Foster, DA
    [J]. ONCOGENE, 2003, 22 (25) : 3937 - 3942
  • [9] Not all substrates are treated equally Implications for mTOR, rapamycin-resistance and cancer therapy
    Choo, Andrew Y.
    Blenis, John
    [J]. CELL CYCLE, 2009, 8 (04) : 567 - 572
  • [10] TOR complex 2: a signaling pathway of its own
    Cybulski, Nadine
    Hall, Michael N.
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2009, 34 (12) : 620 - 627
123456789